Company Overview

Morphle Labs develops robotic microscopy platforms for cancer diagnostics automation, addressing histopathology workflows with AI-driven imaging and robotics. The company raised $5M Series A in November 2025 led by Inflexor Ventures to revolutionize cancer diagnostics with physical AI. Morphle's flagship platforms include RoboTome (robotic microtome slicing biopsy blocks at 2x speed of experienced histotechnologists) and MorphoLens (high-throughput slide scanner digitizing 100+ slides/hour). With 80+ patents filed and products used in leading US and European laboratories, the 100-member team (Bengaluru and Boston) is expanding manufacturing, regulatory clearances, and global presence.

Revenue
$5M
Loading News...
Loading Timeline...
Loading Culture...
Loading Leadership...

Open Positions

Reddit Discussions

Loading Competitive Intelligence...

Key Differentiators

Emerging Innovator

Morphle Labs is an emerging player bringing innovative solutions to the Healthcare market.

Frequently Asked Questions

AI Visibility Rankings

How Morphle Labs performs in AI search results

AI Rank
?
Track your position
Platforms
5
ChatGPT, Gemini, Claude...
Visibility
?
Your mention rate
Premium Feature

Unlock AI Visibility Tracking for Morphle Labs

See exactly how Morphle Labs ranks across ChatGPT, Gemini, Perplexity, Claude, and Grok. Get actionable insights to improve your AI search performance.

Real-time Rankings
Track your position daily
Competitive Intel
See how you compare
Platform Breakdown
Per-AI performance
Actionable Insights
Optimize your visibility
Start Tracking for Free

Join 1,000+ brands · Free 7-day trial · No credit card required

Want to improve your AI visibility? Track performance across all major AI platforms.
Compare with Other Brands

Compare with Other Brands

See how Morphle Labs stacks up against competitors with our detailed comparison tool.

Start Comparison